Randomized double-blinded controlled trial on the effect of synbiotic supplementation on IL-17/IL-23 pathway and disease activity in patients with axial spondyloarthritis

References

• Sieper J, Poddubnyy D. Axial spondyloarthritis. Lancet. 2017;390(10089):73–84.
   PubMed Web of Science ®Google Scholar
• Roozbehkia M, Mahmoudi M, Aletaha S, et al. The potent suppressive effect of β-d-mannuronic acid (M2000) on molecular expression of the TLR/NF-kB signaling pathway in ankylosing spondylitis patients. Int Immunopharmacol. 2017;52:191–196.
   PubMed Web of Science ®Google Scholar
• Zhu W, He X, Cheng K, et al. Ankylosing spondylitis: etiology, pathogenesis, and treatments. Bone Res. 2019;7(1):1–16.
   PubMedGoogle Scholar
• Yang L, Wang L, Wang X, et al. A possible role of intestinal microbiota in the pathogenesis of ankylosing spondylitis. IJMS. 2016;17(12):2126.
   Google Scholar
• Miossec P, Kolls JK. Targeting IL‐17 and TH17 cells in chronic inflammation. Nat Rev Drug Discov. 2012;11(10):763–776.
   PubMed Web of Science ®Google Scholar
• van Hamburg JP, Tas SW. Molecular mechanisms underpinning T helper 17 cell heterogeneity and functions in rheumatoid arthritis. J Autoimmun. 2018;87:69–81.
   PubMed Web of Science ®Google Scholar
• Mei Y, Pan F, Gao J, et al. Increased serum IL-17 and IL-23 in the patient with ankylosing spondylitis. Clin Rheumatol. 2011;30(2):269–273.
   PubMed Web of Science ®Google Scholar
• Hajialilo M, Dolati S, Abdolmohammadi-Vahid S, et al. Nanocurcumin: a novel strategy in treating ankylosing spondylitis by modulating Th17 cells frequency and function. J Cell Biochem. 2019;120(7):12027–12038.
   Web of Science ®Google Scholar
• Appel H, Maier R, Wu P, et al. Analysis of IL-17(+) cells in facet joints of patients with spondyloarthritis suggests that the innate immune pathway might be of greater relevance than the Th17-mediated adaptive immune response. Arthritis Res Ther. 2011;13(3):R95.
   PubMed Web of Science ®Google Scholar
• Langrish CL, Chen Y, Blumenschein WM, et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med. 2005;201(2):233–240.
   PubMed Web of Science ®Google Scholar
• Reveille JD, Sims AM, Danoy P, Australo-Anglo-American Spondyloarthritis Consortium (TASC), et al. Genome-wide association study of ankylosing spondylitis identifies non-MHC susceptibility loci. Nat Genet. 2010;42(2):123–127.
   PubMed Web of Science ®Google Scholar
• Zeng L, Lindstrom MJ, Smith JA. Ankylosing spondylitis macrophage production of higher levels of interleukin-23 in response to lipopolysaccharide without induction of a significant unfolded protein response. Arthritis Rheum. 2011;63(12):3807–3817.
   PubMed Web of Science ®Google Scholar
• Babaie F, Hasankhani M, Mohammadi H, et al. The role of gut microbiota and IL-23/IL-17 pathway in ankylosing spondylitis immunopathogenesis: New insights and updates. Immunol Lett. 2018;196:52–62.
   PubMed Web of Science ®Google Scholar
• Paine A, Ritchlin CT. Targeting the interleukin-23/17 axis in axial spondyloarthritis. Curr Opin Rheumatol. 2016;28(4):359–367.
   PubMed Web of Science ®Google Scholar
• de Vrese M, Schrezenmeir J. Probiotics, prebiotics, and synbiotics. Adv Biochem Eng Biotechnol. 2008;111:1–66.
   PubMed Web of Science ®Google Scholar
• Frece J, Kos B, Svetec IK, et al. Synbiotic effect of Lactobacillus helveticus M92 and prebiotics on the intestinal microflora and immune system of mice. J Dairy Res. 2009;76(1):98–104.
   PubMed Web of Science ®Google Scholar
• Worthley DL, Le Leu RK, Whitehall VL, et al. A human, double-blind, placebo-controlled, crossover trial of prebiotic, probiotic, and synbiotic supplementation: effects on luminal, inflammatory, epigenetic, and epithelial biomarkers of colorectal cancer. Am J Clin Nutr. 2009;90(3):578–586.
   PubMed Web of Science ®Google Scholar
• Alipour B, Homayouni-Rad A, Vaghef-Mehrabany E, et al. Effects of Lactobacillus casei supplementation on disease activity and inflammatory cytokines in rheumatoid arthritis patients: a randomized double-blind clinical trial. Int J Rheum Dis. 2014;17(5):n/a–27. 2014;
   Web of Science ®Google Scholar
• Zamani B, Golkar HR, Farshbaf S, et al. Clinical and metabolic response to probiotic supplementation in patients with rheumatoid arthritis: a randomized, double-blind, placebo-controlled trial. Int J Rheum Dis. 2016;19(9):869–879.
   PubMed Web of Science ®Google Scholar
• Zamani B, Farshbaf S, Golkar HR, et al. Synbiotic supplementation and the effects on clinical and metabolic responses in patients with rheumatoid arthritis: a randomised, double-blind, placebo-controlled trial. Br J Nutr. 2017;117(8):1095–1102.
   PubMed Web of Science ®Google Scholar
• Pineda MdLA, Thompson SF, Summers K, et al. A randomized, double-blinded, placebo-controlled pilot study of probiotics in active rheumatoid arthritis. Med Sci Monit. 2011;17(6):CR347–54.
   PubMed Web of Science ®Google Scholar
• Hatakka K, Martio J, Korpela M, et al. Effects of probiotic therapy on the activity and activation of mild rheumatoid arthritis–a pilot study. Scand J Rheumatol. 2003;32(4):211–215.
   PubMed Web of Science ®Google Scholar
• Jenks K, Stebbings S, Burton J, et al. Probiotic therapy for the treatment of spondyloarthritis: a randomized controlled trial. J Rheumatol. 2010;37(10):2118–2125.
   PubMed Web of Science ®Google Scholar
• Brophy S, Burrows CL, Brooks C, et al. Internet-based randomised controlled trials for the evaluation of complementary and alternative medicines: probiotics in spondyloarthropathy. BMC Musculoskelet Disord. 2008;9:4.
   PubMed Web of Science ®Google Scholar
• Askari G, Moravejolahkami AR. Synbiotic supplementation may relieve anterior uveitis, an ocular manifestation in behcet's syndrome. Am J Case Rep. 2019;20:548–550.
   PubMed Web of Science ®Google Scholar
• van den Berg R, de Hooge M, Rudwaleit M, et al. ASAS modification of the Berlin algorithm for diagnosing axial spondyloarthritis: results from the SPondyloArthritis caught early (SPACE)-cohort and from the assessment of SpondyloArthritis international society (ASAS)-cohort. Ann Rheum Dis. 2013;72(10):1646–1653.
   PubMed Web of Science ®Google Scholar
• Garrett S, Jenkinson T, Kennedy LG, et al. A new approach to defining disease status in ankylosing spondylitis: the bath ankylosing spondylitis disease activity index. J Rheumatol. 1994;21(12):2286–2291.
   PubMed Web of Science ®Google Scholar
• Lukas C, Landewé R, Sieper J, Assessment of SpondyloArthritis international Society, et al. Assessment of SpondyloArthritis international society development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis. Ann Rheum Dis. 2009;68(1):18–24.
   PubMed Web of Science ®Google Scholar
• Askari G, Ghavami A, Shahdadian F, et al. Effect of synbiotics and probiotics supplementation on autoimmune diseases: a systematic review and meta-analysis of clinical trials. Clin Nutr. 2021;40(5):3221–3234.
   PubMed Web of Science ®Google Scholar
• Rizzo A, Losacco A, Carratelli CR, et al. Lactobacillus plantarum reduces Streptococcus pyogenes virulence by modulating the IL-17, IL-23 and toll-like receptor 2/4 expressions in human epithelial cells. Int Immunopharmacol. 2013;17(2):453–461.
   PubMed Web of Science ®Google Scholar
• Ghadimi D, Helwig U, Schrezenmeir J, et al. Epigenetic imprinting by commensal probiotics inhibits the IL-23/IL-17 axis in an in vitro model of the intestinal mucosal immune system. J Leukoc Biol. 2012;92(4):895–911. 2012;
   PubMed Web of Science ®Google Scholar
• Martins AJ, Colquhoun P, Reid G, et al. Reduced expression of basal and probiotic-inducible G-CSF in intestinal mononuclear cells is associated with inflammatory bowel disease. Inflamm Bowel Dis. 2009;15(4):515–525.
   PubMed Web of Science ®Google Scholar
• Zhang B, An J, Shimada T, et al. Oral administration of Enterococcus faecalis FK-23 suppresses Th17 cell development and attenuates allergic airway responses in mice. Int J Mol Med. 2012;30(2):248–254.
   PubMed Web of Science ®Google Scholar
• Letnická A, Karaffová V, Levkut M, et al. Influence of oral application of Enterococcus faecium AL41 on TGF-β4 and IL-17 expression and immunocompetent cell distribution in chickens challenged with Campylobacter jejuni. Acta Vet Hung. 2017;65(3):317–326.
   PubMed Web of Science ®Google Scholar
• Mardani F, Mahmoudi M, Esmaeili SA, et al. In vivo study: Th1-Th17 reduction in pristane-induced systemic lupus erythematosus mice after treatment with tolerogenic lactobacillus probiotics. J Cell Physiol. 2018;234(1):642–649.
   PubMed Web of Science ®Google Scholar
• Xie Y, Zhou L, Yao X, et al. Protective effects of Clostridium Butyricum in a murine model of dextran sodium Sulfate-Induced colitis that involve inhibition of the TLR2 signaling pathway and T helper 17 cells. Am J Med Sci. 2020;360(2):176–191.
   PubMed Web of Science ®Google Scholar
• Chen L, Zou Y, Peng J, et al. Lactobacillus acidophilus suppresses colitis-associated activation of the IL-23/Th17 axis. J Immunol Res. 2015;2015:909514.
   PubMed Web of Science ®Google Scholar
• Darbaky Y, Evrard B, Patrier S, et al. Oral probiotic treatment of Lactobacillus rhamnosus Lcr35® prevents visceral hypersensitivity to a colonic inflammation and an acute psychological stress. J Appl Microbiol. 2017;122(1):188–200.
   PubMed Web of Science ®Google Scholar
• Amdekar S, Singh V, Kumar A, et al. Lactobacillus casei and Lactobacillus acidophilus regulate inflammatory pathway and improve antioxidant status in collagen-induced arthritic rats. J Interferon Cytokine Res. 2013;33(1):1–8.
   PubMed Web of Science ®Google Scholar
• Dehnavi S, Azad FJ, Hoseini RF, et al. A significant decrease in the gene expression of interleukin-17 following the administration of synbiotic in patients with allergic rhinitis who underwent immunotherapy: a placebo-controlled clinical trial. J Res Med Sci. 2019;24:51.
   PubMed Web of Science ®Google Scholar
• Neyrinck AM, Rodriguez J, Taminiau B, et al. Improvement of gastrointestinal discomfort and inflammatory status by a synbiotic in Middle-aged adults: a double-blind randomized placebo-controlled trial. Sci Rep. 2021;11(1):2627.
   PubMed Web of Science ®Google Scholar
• Szkaradkiewicz AK, Stopa J, Karpiński TM. Effect of oral administration involving a probiotic strain of Lactobacillus reuteri on pro-inflammatory cytokine response in patients with chronic periodontitis. Arch Immunol Ther Exp (Warsz). 2014;62(6):495–500.
   PubMed Web of Science ®Google Scholar
• Shukla A, Gaur P, Aggarwal A. Effect of probiotics on clinical and immune parameters in enthesitis-related arthritis category of juvenile idiopathic arthritis. Clin Exp Immunol. 2016;185(3):301–308.
   PubMed Web of Science ®Google Scholar
• Inoue Y, Kambara T, Murata N, et al. Effects of oral administration of Lactobacillus acidophilus L-92 on the symptoms and serum cytokines of atopic dermatitis in Japanese adults: a double-blind, randomized, clinical trial. Int Arch Allergy Immunol. 2014;165(4):247–254.
   PubMed Web of Science ®Google Scholar
• Wang IK, Wu YY, Yang YF, et al. The effect of probiotics on serum levels of cytokine and endotoxin in peritoneal dialysis patients: a randomised, double-blind, placebo-controlled trial. Benef Microbes. 2015;6(4):423–430.
   PubMed Web of Science ®Google Scholar
• Smecuol E, Hwang HJ, Sugai E, et al. Exploratory, randomized, double-blind, placebo-controlled study on the effects of bifidobacteriuminfantisnatren life start strain super strain in active celiac disease. J Clin Gastroenterol. 2013;47(2):139–147.
   PubMed Web of Science ®Google Scholar
• Owaga E, Hsieh RH, Mugendi B, et al. Th17 cells as potential probiotic therapeutic targets in inflammatory bowel diseases. Int J Mol Sci. 2015;16(9):20841–20858.
   PubMed Web of Science ®Google Scholar
• Tanabe S. The effect of probiotics and gut microbiota on Th17 cells. Int Rev Immunol. 2013;32(5-6):511–525.
   PubMed Web of Science ®Google Scholar
• Rudwaleit M, Olivieri I, Boki KA, et al. Adalimumab is effective and well tolerated in treating patients with ankylosing spondylitis who have advanced spinal fusion. Rheumatology (Oxford). 2008;48(5):551–557.
   Web of Science ®Google Scholar
• Esmaeili F, Salesi M, Askari G, et al. Efficacy of synbiotic supplementation in improving rheumatoid arthritis. Res Pharm Sci. 2020;15(3):263–272.
   PubMed Web of Science ®Google Scholar
• Vaghef-Mehrabany E, Alipour B, Homayouni-Rad A, et al. Probiotic supplementation improves inflammatory status in patients with rheumatoid arthritis. Nutrition. 2014;30(4):430–435.
   PubMed Web of Science ®Google Scholar
• Mandel DR, Eichas K, Holmes J. Bacillus coagulans: a viable adjunct therapy for relieving symptoms of rheumatoid arthritis according to a randomized, controlled trial. BMC Complement Altern Med. 2010;10:1.
   PubMed Web of Science ®Google Scholar